Status:
TERMINATED
A Study of the Expression of Nogo and Reticulon Genes in Skeletal Muscle of Patients With Amyotrophic Lateral Sclerosis
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Amyotrophic Lateral Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
This is a study of the expression of nogo and reticulon genes in the skeletal muscle of patients with amyotrophic lateral sclerosis (ALS).
Eligibility Criteria
Inclusion
- Patients with definite ALS
- Males or females
- Age \> 18
Exclusion
- Patients with other neuromuscular affections
Key Trial Info
Start Date :
February 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT00213824
Start Date
February 1 2004
End Date
July 1 2012
Last Update
March 27 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique Neurologique, Service des Maladies du Système Nerveux et du Muscle, Hôpital Civil, Hôpitaux Universitaires
Strasbourg, France, 67091